$0.00200
At close: Feb 21, 3:32 PM EDT
Comments
Loading...
Amexdrug Analyst Ratings and Price Targets | OTC:AXRX | Benzinga
Amexdrug Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Amexdrug Corp from these most-recent analyst ratings.
Analyst Ratings for Amexdrug
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Amexdrug (AXRX) stock?
There is no price target for Amexdrug
What is the most recent analyst rating for Amexdrug (AXRX)?
There is no analyst for Amexdrug
When was the last upgrade for Amexdrug (AXRX)?
There is no last upgrade for Amexdrug
When was the last downgrade for Amexdrug (AXRX)?
There is no last downgrade for Amexdrug.
When is the next analyst rating going to be posted or updated for Amexdrug (AXRX)?
There is no next analyst rating for Amexdrug.
Is the Analyst Rating Amexdrug (AXRX) correct?
There is no next analyst rating for Amexdrug.
Browse analyst ratings and price targets on all stocks.
